TIVA-tag for Spatially Controlled RNA Isolation in Live Cells

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods are limited in quantifying gene expression in individual live cells within intact functioning tissues due to challenges in isolating RNA from complex, intact tissues where cells are tightly intermingled, and existing techniques lack the ability to combine RNA analysis with live-imaging or electrophysiology for novel insights into in vivo functioning.

Innovation Solution

A hybrid nucleic acid molecule with photocleavable linkers and a cell-penetrating domain is introduced into cells, allowing spatially controlled activation to capture and isolate RNA specifically within the activated cell, enabling the isolation of nuclear or cellular RNA with high spatial and temporal resolution.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If existing techniques (in situ transcription, FACS-array, LCM) are used to generate gene expression information from single cells in situ, then RNA can be analyzed from individual cells, but the ability to combine RNA analysis with other in vivo techniques (live-imaging, electrophysiology) is limited

Engineering Contradiction:
Improvegene expression quantificationVSAvoidcombination with in vivo techniques
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The method segments the RNA capture process into distinct functional components: a cell-penetrating domain for cellular entry, a photocleavable linker for temporal control, and an RNA-binding oligonucleotide for specific capture. This segmentation allows each component to be optimized independently and enables integration with other in vivo techniques without interfering with the overall process.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The TIVA-tag molecule is introduced into cells and positioned within the nucleus before the actual RNA capture is initiated. The photocleavable linker keeps the RNA-binding oligonucleotide in a dormant state until light activation occurs. This preliminary positioning combined with temporal control through photocleavage enables precise spatiotemporal RNA capture that can be coordinated with live-imaging or electrophysiological recordings.

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If single cells are isolated from intact tissues for RNA analysis, then gene expression can be measured, but the complex structure of intact tissues with tightly intermingled cells complicates the isolation process

Engineering Contradiction:
Improvesingle cell RNA analysisVSAvoidtissue isolation process
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

Instead of physically isolating single cells from intact tissues through complex procedures, the method extracts only the necessary function (RNA capture) by introducing a synthetic TIVA-tag molecule that selectively binds RNA within the cell of interest. The molecule remains in situ within the cell, capturing RNA without requiring physical separation from the tissue architecture.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The TIVA-tag molecule acts as an intermediary that bridges the gap between the researcher and the intracellular RNA. Rather than directly manipulating cells or tissues, the researcher introduces this synthetic mediator that penetrates cell membranes, localizes to the nucleus, and specifically captures RNA through its oligonucleotide component, thereby simplifying the overall process.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If a molecule is introduced into cells to capture RNA, then RNA can be isolated from individual cells, but spatial control over where and when capture occurs is required to avoid capturing RNA from neighboring cells

Engineering Contradiction:
ImproveRNA capture specificityVSAvoidspatial and temporal control
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The TIVA-tag molecule exhibits local quality through its spatial localization to the cell nucleus and its selective activation by light. The photocleavable linker ensures that the RNA-binding oligonucleotide is only activated in specific spatiotemporal contexts, allowing RNA capture to occur only in the intended cell and at the intended time, thereby achieving high specificity without cross-contamination from neighboring cells.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The method utilizes parameter changes through light activation to control the transition of the TIVA-tag from an inactive state (with the photocleavable linker intact) to an active state (after photocleavage). By controlling the timing and location of light exposure, the researcher can precisely regulate when and where RNA capture occurs, achieving both spatial and temporal precision.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the precise isolation of RNA from individual live cells, providing a detailed molecular fingerprint that can highlight systemic constraints and influences on cell functioning, particularly in disease states like Alzheimer's, and can be applied to various cellular environments, including live tissue slices and intact animals.

Implementation Method 1

the molecule is activated in the at least one cell, or cellular compartment, the molecule captures RNA only in the at least one cell or cellular compartment where the molecule has been activated

Methodology Applied
Scientific EffectPhotodissociation: Photodissociation

Data Source

PatentUS9540680B2Transcriptome in vivo analysis
Publication Date: 2017.01.10 THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
  • US9540680B2 patent drawing
  • US9540680B2 patent drawing
  • US9540680B2 patent drawing

AI summary

The invention provides compositions and methods that permit a hybrid nucleic acid molecule to enter a cell and when specifically activated within the cell, the molecule anneals to endogenous cellular RNA and permits the isolation of the RNA.